Superdisintegrants Market Analysis By Product (Croscarmellose sodium, Crospovidone, Sodium starch glycolate, Ion exchange resin), By Dosage Form (Tablets and Capsules, Mouth-dissolving Films), And Segment Forecasts, 2014 - 2025

Published: Aug, 2017 | Pages: 100 | Publisher: Grand View Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)

The global superdisintegrants market is expected to reach USD 487.0 million by 2025, according to a new report by Grand View Research, Inc. Superdisintegrants help in the disintegration of tablet or capsule content into small particles and create a greater surface area for speedy drug release.

A number of fast disintegrating tablet such as salbutamol sulphate, and cetirizine hydrochloride in tablet/capsule dosage form for respiratory disorders (bronchitis, asthma, and coughing) are formulated for pediatric and geriatric patients, due to their difficulty or discomfort in swallowing. Superdisintegrant such as crospovidone, croscarmellose sodium, and sodium starch glycolate are used in optimized concentration to formulate such tablets/capsules along with different binders such as MCC and PVP K-30.

Further Key Findings from the Study Suggest:

• The market study suggests that crospovidone dominated the overall market in 2016. Crospovidone is completely insoluble in water and rapidly disperses and swells in water. It has greatest rate of swelling and surface area to volume ratio compared to other disintegrants. Hence, these factors are contributing towards the large share of crospovidone in 2016.

• Others segment, which includes natural superdisintegrants, is expected to witness highest growth rate. Factors such as local accessibility, bio-acceptable, renewable source, eco?friendly nature and lower prices compared to important synthetic products, are driving the growth of the segment during the forecast period.

• Amongst the dosage form segments, tablets and capsules occupied the largest share in 2016 as they are the most common and preferred dosage forms for delivering drugs to patients.

• The mouth-dissolving films segment is expected to grow at the highest growth rate during the forecast period. It is the preferred choice for patients as compared to tablets and capsules due to greater flexibility and comfort of the former.

• Hence, the market for disintegrants in mouth-dissolving films would continue to grow due to quicker onset of action for a dosage form and better convenience of administration.

• North America dominated the regional segment with the largest revenue share in 2016, due to number of superdisintegrants manufacturers operating in the region and prolific research and development initiatives

• Asia Pacific is expected to witness significant growth during the forecast period, owing to booming medical tourism industry in the region and lucrative contract research outsourcing services

• Some of the major companies operating in this market are Ashland Global Holdings Inc., Roquette Freres S.A., FMC Corporation, DFE Pharma, Huber Corporation, Nippon Soda Co., Ltd. The Dow Chemical Company and BASF SE. and others.

 Table of Contents

Chapter 1 Research Methodology
               1.1 Information Procurement
               1.2 Data Analysis
               1.3 Approaches for Market Estimation
                   1.3.1 Approach 1: Demand analysis &bottom-up approach
                   1.3.2 Approach 2: Top-down market estimation
                   1.3.3 Approach 3: Commodity flow and bottom-up market estimation
                   1.3.4 Approach 4: KoL perspective-based market sizing
Chapter 2 Executive Summary
               2.1 Market Snapshot 
Chapter 3 Superdisintegrants Market Variables, Trends & Scope
               3.1 Market Segmentation
               3.2 Market Size and Growth Prospects
                   3.2.1 Market driver analysis
                   3.2.2 Market restraint analysis
               3.3 Key Opportunities Prioritized
               3.4 Industry Analysis Porter's
               3.5 PESTEL Analysis
Chapter 4 Superdisintegrants Market: Product Estimates & Trend Analysis
               4.1 Superdisintegrants Market: Product Movement Analysis, 2016 & 2025
               4.2 Croscarmellose sodium
                   4.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
               4.3 Crospovidone
                   4.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
               4.4 Sodium starch glycolate 
                   4.4.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
               4.5 Ion exchange resin
                   4.5.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
               4.6 Others
                   4.6.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 5 Superdisintegrants Market: Dosage Form Estimates & Trend Analysis
               5.1 Superdisintegrants Market: Dosage form Analysis, 2016 & 2025
               5.2 Tablets and Capsules
                   5.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
               5.3 Mouth-dissolving Films 
                   5.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 6 Superdisintegrants Market: Regional Estimates & Trend Analysis, by Product & Dosage Form
               6.1 Superdisintegrants Market Share by Region, 2016 & 2025
               6.2 North America
                   6.2.1 U.S.
                       6.2.1.1 Market estimates and forecasts, by product, 2014 - 2025
                       6.2.1.2 Market estimates and forecasts, by dosage form, 2014 - 2025
                   6.2.2 Canada
                       6.2.2.1 Market estimates and forecasts, by product, 2014 - 2025
                       6.2.2.2 Market estimates and forecasts, by dosage form, 2014 - 2025
               6.3 Europe
                   6.3.1 UK
                       6.3.1.1 Market estimates and forecasts, by product, 2014 - 2025
                       6.3.1.2 Market estimates and forecasts, by dosage form, 2014 - 2025
                   6.3.2 Germany
                       6.3.2.1 Market estimates and forecasts, by product, 2014 - 2025
                       6.3.2.2 Market estimates and forecasts, by dosage form, 2014 - 2025
               6.4 Asia Pacific
                   6.4.1 China
                       6.4.1.1 Market estimates and forecasts, by product, 2014 - 2025
                       6.4.1.2 Market estimates and forecasts, by dosage form, 2014 - 2025
                   6.4.2 Japan
                       6.4.2.1 Market estimates and forecasts, by product, 2014 - 2025
                       6.4.2.2 Market estimates and forecasts, by dosage form, 2014 - 2025
               6.5 Latin America
                   6.5.1 Brazil
                       6.5.1.1 Market estimates and forecasts, by product, 2014 - 2025
                       6.5.1.2 Market estimates and forecasts, by dosage form, 2014 - 2025
                   6.5.2 Mexico
                       6.5.2.1 Market estimates and forecasts, by product, 2014 - 2025
                       6.5.2.2 Market estimates and forecasts, by dosage form, 2014 - 2025
               6.6 MEA
                   6.6.1 South Africa
                       6.6.1.1 Market estimates and forecasts, by product, 2014 - 2025
                       6.6.1.2 Market estimates and forecasts, by dosage form, 2014 - 2025
Chapter 7 Competitive Landscape
               7.1 Strategy Framework
               7.2 Company Profiles
                   7.2.1 Ashland Global Holdings Inc.
                       7.2.1.1 Company overview
                       7.2.1.2 Financial performance
                       7.2.1.3 Product benchmarking
                       7.2.1.4 Strategic initiatives
                   7.2.2 Roquette Freres S.A.
                       7.2.2.1 Company overview
                       7.2.2.2 Financial performance
                       7.2.2.3 Product benchmarking
                       7.2.2.4 Strategic initiatives
                   7.2.3 FMC Corporation 
                       7.2.3.1 Company overview
                       7.2.3.2 Financial performance
                       7.2.3.3 Product benchmarking
                       7.2.3.4 Strategic initiatives
                   7.2.4 DFE Pharma 
                       7.2.4.1 Company overview
                       7.2.4.2 Financial performance
                       7.2.4.3 Product benchmarking
                       7.2.4.4 Strategic initiatives
                   7.2.5 Huber Corporation 
                       7.2.5.1 Company overview
                       7.2.5.2 Financial performance
                       7.2.5.3 Product benchmarking
                       7.2.5.4 Strategic initiatives
                   7.2.6 Nippon Soda Co., Ltd. 
                       7.2.6.1 Company overview
                       7.2.6.2 Financial performance
                       7.2.6.3 Product benchmarking
                       7.2.6.4 Strategic initiatives
                   7.2.7 The Dow Chemical Company 
                       7.2.7.1 Company overview
                       7.2.7.2 Financial performance
                       7.2.7.3 Product benchmarking
                       7.2.7.4 Strategic initiatives
                   7.2.8 BASF SE 
                       7.2.8.1 Company overview
                       7.2.8.2 Financial performance
                       7.2.8.3 Product benchmarking
                       7.2.8.4 Strategic initiatives

List of Tables

TABLE 1 Superdisintegrants market - industry snapshot
TABLE 2 Superdisintegrants market, by product, 2014 - 2025 (USD Million)
TABLE 3 Superdisintegrants market, by dosage form, 2014 - 2025 (USD Million)
TABLE 4 Superdisintegrants market, by region, 2014 - 2025 (USD Million)
TABLE 5 Superdisintegrants market: Key market driver analysis
TABLE 6 Superdisintegrants market: Key market restraint analysis
TABLE 7 North America market, by product 2014 - 2025 (USD Million)
TABLE 8 North America market, by dosage form 2014 - 2025 (USD Million)
TABLE 9 U.S. market, by product 2014 - 2025 (USD Million)
TABLE 10 U.S. market, by dosage form 2014 - 2025 (USD Million)
TABLE 11 Canada market, by product 2014 - 2025 (USD Million)
TABLE 12 Canada market, by dosage form2014 - 2025 (USD Million)
TABLE 13 Europe market, by product 2014 - 2025 (USD Million)
TABLE 14 Europe market, by dosage form2014 - 2025 (USD Million)
TABLE 15 UK market, by product 2014 - 2025 (USD Million)
TABLE 16 UK market, by dosage form 2014 - 2025 (USD Million)
TABLE 17 Germany market, by product 2014 - 2025 (USD Million)
TABLE 18 Germany market, by dosage form 2014 - 2025 (USD Million)
TABLE 19 Asia Pacific market, by product 2014 - 2025 (USD Million)
TABLE 20 Asia Pacific market, by dosage form 2014 - 2025 (USD Million)
TABLE 21 Japan market, by product 2014 - 2025 (USD Million)
TABLE 22 Japan market, by dosage form 2014 - 2025 (USD Million)
TABLE 23 China market, by product 2014 - 2025 (USD Million)
TABLE 24 China market, by dosage form 2014 - 2025 (USD Million)
TABLE 25 Latin America market, by product 2014 - 2025 (USD Million)
TABLE 26 Latin America market, by dosage form 2014 - 2025 (USD Million)
TABLE 27 Brazil market, by product 2014 - 2025 (USD Million)
TABLE 28 Brazil market, by dosage form 2014 - 2025 (USD Million)
TABLE 29 Mexico market, by product 2014 - 2025 (USD Million)
TABLE 30 Mexico market, by dosage form 2014 - 2025 (USD Million)
TABLE 31 MEA market, by product 2014 - 2025 (USD Million)
TABLE 32 MEA market, by dosage form 2014 - 2025 (USD Million)
TABLE 33 South Africa market, by product 2014 - 2025 (USD Million)
TABLE 34 South Africa market, by dosage form 2014 - 2025 (USD Million)